What is Wall Street's Target Price for Genocea Biosciences Inc (GNCA) Stock Monday?

Monday, April 11, 2022 09:43 AM | InvestorsObserver Analysts

Mentioned in this article

What is Wall Street's Target Price for Genocea Biosciences Inc (GNCA) Stock Monday?

InvestorsObserver is giving Genocea Biosciences Inc (GNCA) an Analyst Rating Rank of 73, meaning GNCA is ranked higher by analysts than 73% of stocks. The average price target for GNCA is $6.566 and analyst’s rate the stock as a Strong Buy.

Wall Street analysts are rating GNCA a Strong Buy today. Find out what this means to you and get the rest of the rankings on GNCA!

See Full GNCA Report

Why are Analyst Ratings Important?

Analysts know the inner workings of the companies they follow better than anyone but the companies’ management. You can learn a lot about a company from studying the financial statements, but analysts ask questions on conference calls and understand the intricacies of each of the businesses they cover. Analysts understand how bad weather in one part of the world can disrupt supply chains, or disrupt shopping patterns. This lets traders make decisions before a quarterly report that could be worse than expected. InvestorsObserver aggregates the ratings of all the analysts covering a given stock, takes the average of those ratings and then percentile ranks the averages. That provides a level of granularity that is significantly better than just the three levels provided by traditional buy/hold/sell ratings.

What's Happening With Genocea Biosciences Inc Stock Today?

Genocea Biosciences Inc (GNCA) stock is trading at $0.69 as of 9:41 AM on Monday, Apr 11, a rise of $0.29, or 72.5% from the previous closing price of $0.40. The stock has traded between $0.55 and $0.70 so far today. Volume today is above average. So far 7,391,142 shares have traded compared to average volume of 576,463 shares. Click Here to get the full Stock Report for Genocea Biosciences Inc stock.